Drug intelligence / Profile preview

I-Fol Plus

Development stage: Unknown
Lead developer: Indo-Bangla Pharma
Modality: Small Molecules
Administration: Oral

Overview

**I-Fol Plus** is an approved oral combination tablet supplement marketed by **Indo-Bangla Pharmaceuticals** for the prevention and treatment of iron deficiency anemia, folate deficiency, and pregnancy-related anemia supplementation. The product contains **ferrous fumarate + folic acid**, a standard small-molecule hematinic combination in which ferrous fumarate supplies elemental iron for hemoglobin production and replenishment of iron stores, while folic acid supports one-carbon metabolism, DNA synthesis, and erythropoiesis. It appears to be a marketed vitamins-and-minerals product rather than a novel clinical-stage asset.

Brand names: I-Fol Plus
Other names: ferrous fumarate + folic acidiron + folic acid supplementFerrous Fumarate & Folic Acid

Targets

DNA

Beyond the preview

Go deeper on I-Fol Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on I-Fol Plus.

Explore the full profile